We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0W4N market cap is 597.17M. The company's latest EPS is EUR 4.7215 and P/E is 7.88.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 33.86M | 34.57M | 41.65M | 42.5M | 77.7M |
| Operating Income | -2.27M | -5.74M | -13.3M | -17.73M | -369k |
| Net Income | -2.29M | -5.93M | -13.48M | 35.99M | 75.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 53.56M | 75.6M | 66.33M | 853.7M | 890.36M |
| Total Liabilities | 5.34M | 7.56M | 10.26M | 497.12M | 387.61M |
| Total Equity | 48.21M | 68.04M | 56.07M | 356.58M | 502.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -1.48M | -5.1M | -14.18M | -18.88M | -9.85M |
| Investing | -5.71M | -648k | -4.24M | -37.07M | -17.38M |
| Financing | 17.24M | 25.64M | 1.35M | 40.74M | 44.44M |
| Market Cap | 597.17M |
| Price to Earnings Ratio | 7.88 |
| Price to Sales Ratio | 7.69 |
| Price to Cash Ratio | 22.09 |
| Price to Book Ratio | 1.19 |
| Dividend Yield | - |
| Shares Outstanding | 16.05M |
| Average Volume (1 week) | 275 |
| Average Volume (1 Month) | 164 |
| 52 Week Change | 0.00% |
| 52 Week High | 37.20 |
| 52 Week Low | 37.20 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Formycon Ag |
| Address |
fraunhoferstr. 15 munich D 82152 |
| Website | https://www.formycon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
